213 related articles for article (PubMed ID: 12434585)
21. The COX-1/COX-2 balance in asthma.
Pang L; Pitt A; Petkova D; Knox AJ
Clin Exp Allergy; 1998 Sep; 28(9):1050-8. PubMed ID: 9761007
[No Abstract] [Full Text] [Related]
22. Cyclooxygenase-2 in human platelets as a possible factor in aspirin resistance.
Weber AA; Zimmermann KC; Meyer-Kirchrath J; Schrör K
Lancet; 1999 Mar; 353(9156):900. PubMed ID: 10093990
[No Abstract] [Full Text] [Related]
23. COX-2 and ALS.
McGeer PL
Amyotroph Lateral Scler Other Motor Neuron Disord; 2001 Sep; 2(3):121-2. PubMed ID: 11771766
[No Abstract] [Full Text] [Related]
24. Cyclooxygenase-2. A key regulator of bladder prostaglandin formation.
Park JM; Schnermann JB; Briggs JP
Adv Exp Med Biol; 1999; 462():171-81. PubMed ID: 10599422
[No Abstract] [Full Text] [Related]
25. Prostaglandins and cyclooxygenases [correction of cycloxygenases] in the spinal cord.
Vanegas H; Schaible HG
Prog Neurobiol; 2001 Jul; 64(4):327-63. PubMed ID: 11275357
[TBL] [Abstract][Full Text] [Related]
26. COX-2 inhibition and the control of pain.
Kiefer W; Dannhardt G
Curr Opin Investig Drugs; 2002 Sep; 3(9):1348-58. PubMed ID: 12498012
[TBL] [Abstract][Full Text] [Related]
27. Expression and enzyme activity determination of human cyclooxygenase-1 and -2 in a baculovirus-insect cell system.
Zhang WY; Yang XN; Jin DZ; Zhu XZ
Acta Pharmacol Sin; 2004 Aug; 25(8):1000-6. PubMed ID: 15301731
[TBL] [Abstract][Full Text] [Related]
28. Elevated spinal cyclooxygenase and prostaglandin release during hyperalgesia in diabetic rats.
Freshwater JD; Svensson CI; Malmberg AB; Calcutt NA
Diabetes; 2002 Jul; 51(7):2249-55. PubMed ID: 12086957
[TBL] [Abstract][Full Text] [Related]
29. Methanesulfonamide group at position-4 of the C-5-phenyl ring of 1,5-diarylpyrazole affords a potent class of cyclooxygenase-2 (COX-2) inhibitors.
Singh SK; Vobbalareddy S; Shivaramakrishna S; Krishnamraju A; Rajjak SA; Casturi SR; Akhila V; Rao YK
Bioorg Med Chem Lett; 2004 Apr; 14(7):1683-8. PubMed ID: 15026050
[TBL] [Abstract][Full Text] [Related]
30. Cyclooxygenase enzymes in allergic inflammation and asthma.
Carey MA; Germolec DR; Langenbach R; Zeldin DC
Prostaglandins Leukot Essent Fatty Acids; 2003; 69(2-3):157-62. PubMed ID: 12895598
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of loxoprofen and its alcohol metabolites for potency and selectivity of inhibition of cyclooxygenase-2.
Riendeau D; Salem M; Styhler A; Ouellet M; Mancini JA; Li CS
Bioorg Med Chem Lett; 2004 Mar; 14(5):1201-3. PubMed ID: 14980665
[TBL] [Abstract][Full Text] [Related]
32. Cyclooxygenase-2 (COX-2) enzyme inhibitors and radiotherapy: preclinical basis.
Milas L
Am J Clin Oncol; 2003 Aug; 26(4):S66-9. PubMed ID: 12902859
[TBL] [Abstract][Full Text] [Related]
33. Cyclooxygenase 2 inhibitors.
Kelley KW; Ramsey LA
Adv Nurse Pract; 2003 Mar; 11(3):22-4. PubMed ID: 12683165
[No Abstract] [Full Text] [Related]
34. Interaction of prostaglandins with the renin-angiotensin system.
Stauss HM
Am J Physiol Regul Integr Comp Physiol; 2003 Apr; 284(4):R1010-1. PubMed ID: 12626362
[No Abstract] [Full Text] [Related]
35. Styrylheterocycles as a novel class inhibitor of cyclooxygenase-2-mediated prostaglandin E(2) production.
Lee SK; Park EJ; Lee E; Min HY; Kim EY; Lee T; Kim S
Bioorg Med Chem Lett; 2004 May; 14(9):2105-8. PubMed ID: 15080988
[TBL] [Abstract][Full Text] [Related]
36. 3-(2-Methoxytetrahydrofuran-2-yl)pyrazoles: a novel class of potent, selective cyclooxygenase-2 (COX-2) inhibitors.
Ranatunge RR; Earl RA; Garvey DS; Janero DR; Letts LG; Martino AM; Murty MG; Richardson SK; Schwalb DJ; Young DV; Zemtseva IS
Bioorg Med Chem Lett; 2004 Dec; 14(24):6049-52. PubMed ID: 15546727
[TBL] [Abstract][Full Text] [Related]
37. COX-2 and COX-2 enzyme inhibition.
Conti P
Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):I-II. PubMed ID: 14552697
[No Abstract] [Full Text] [Related]
38. Constitutive spinal cyclooxygenase-2 participates in the initiation of tissue injury-induced hyperalgesia.
Ghilardi JR; Svensson CI; Rogers SD; Yaksh TL; Mantyh PW
J Neurosci; 2004 Mar; 24(11):2727-32. PubMed ID: 15028765
[TBL] [Abstract][Full Text] [Related]
39. Correspondence re: Cotterchio et al., Nonsteroidal anti-inflammatory drug use and breast cancer risk. Cancer Epidemiol. Biomark. Prev., 10: 1213-1217, 2001.
Mokbel K; Singh-Ranger G; Kirkpatrick K
Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):674; author reply 674. PubMed ID: 12101118
[No Abstract] [Full Text] [Related]
40. Inhibition of cyclooxygenases reduces complement-induced glomerular epithelial cell injury and proteinuria in passive Heymann nephritis.
Takano T; Cybulsky AV; Cupples WA; Ajikobi DO; Papillon J; Aoudjit L
J Pharmacol Exp Ther; 2003 Apr; 305(1):240-9. PubMed ID: 12649375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
